Mesa Laboratories, Inc.
MLAB
$125.73
$3.402.78%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 62.84M | 57.83M | 58.17M | 58.90M | 53.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 62.84M | 57.83M | 58.17M | 58.90M | 53.47M |
| Cost of Revenue | 23.09M | 21.92M | 20.14M | 21.53M | 20.07M |
| Gross Profit | 39.75M | 35.91M | 38.03M | 37.37M | 33.40M |
| SG&A Expenses | 28.92M | 27.31M | 26.93M | 29.38M | 29.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.06M | 53.87M | 51.81M | 56.11M | 53.54M |
| Operating Income | 5.78M | 3.96M | 6.36M | 2.79M | -67.00K |
| Income Before Tax | -2.22M | 3.81M | 3.91M | -275.33M | 1.95M |
| Income Tax Expenses | -541.00K | 384.00K | 517.00K | -20.75M | -170.00K |
| Earnings from Continuing Operations | -1.68M | 3.43M | 3.39M | -254.58M | 2.12M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.68M | 3.43M | 3.39M | -254.58M | 2.12M |
| EBIT | 5.78M | 3.96M | 6.36M | 2.79M | -67.00K |
| EBITDA | 11.28M | 10.03M | 11.82M | 9.09M | 8.98M |
| EPS Basic | -0.31 | 0.63 | 0.63 | -47.20 | 0.39 |
| Normalized Basic EPS | -0.26 | 0.49 | 0.17 | -0.15 | 0.23 |
| EPS Diluted | -0.31 | 0.63 | 0.62 | -47.20 | 0.39 |
| Normalized Diluted EPS | -0.26 | 0.49 | 0.17 | -0.15 | 0.23 |
| Average Basic Shares Outstanding | 5.43M | 5.41M | 5.40M | 5.39M | 5.39M |
| Average Diluted Shares Outstanding | 5.43M | 5.47M | 5.42M | 5.39M | 5.40M |
| Dividend Per Share | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 |
| Payout Ratio | -51.85% | 25.26% | 25.47% | -0.34% | 40.74% |
